Soleus Capital Master Fund, L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, 4, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-07
4:00 pm
Sale
2025-09-3013GMural Oncology plc
MURA
Soleus Capital Master Fund, L.P.0
0.000%
-1,323,877decrease
(Position Closed)
Filing
History
2025-11-07
4:00 pm
Sale
2025-09-3013GSTAAR Surgical Company
STAA
Soleus Capital Master Fund, L.P.500,000
1.000%
-2,062,893decrease
(-80.49%)
Filing
History
2025-11-07
4:00 pm
Purchase
2025-09-3013GNovoCure Limited
NVCR
Soleus Capital Master Fund, L.P.9,644,872
8.600%
2,740,570increase
(+39.69%)
Filing
History
2025-11-07
4:00 pm
Sale
2025-09-3013GSurmodics, Inc.
SRDX
Soleus Capital Master Fund, L.P.0
0.000%
-739,060decrease
(Position Closed)
Filing
History
2025-08-05
5:00 pm
Sale
2025-06-3013GUroGen Pharma Ltd.
URGN
Soleus Capital Master Fund, L.P.2,185,000
4.700%
-140,000decrease
(-6.02%)
Filing
History
2025-08-05
5:00 pm
Sale
2025-06-3013GRigel Pharmaceuticals, Inc.
RIGL
Soleus Capital Master Fund, L.P.658,145
3.700%
-472,534decrease
(-41.79%)
Filing
History
2025-08-05
5:00 pm
Purchase
2025-06-3013GMural Oncology plc
MURA
Soleus Capital Master Fund, L.P.1,323,877
7.600%
243,950increase
(+22.59%)
Filing
History
2025-08-05
5:00 pm
Sale
2025-06-3013GPraxis Precision Medicines, Inc.
PRAX
Soleus Capital Master Fund, L.P.966,740
4.600%
-51,000decrease
(-5.01%)
Filing
History
2025-08-05
5:00 pm
Purchase
2025-06-3013GNeuroPace, Inc.
NPCE
Soleus Capital Master Fund, L.P.2,303,828
7.000%
2,303,828increase
(New Position)
Filing
History
2025-08-05
5:00 pm
Purchase
2025-06-3013GNovoCure Limited
NVCR
Soleus Capital Master Fund, L.P.6,904,302
6.200%
1,382,888increase
(+25.05%)
Filing
History
2025-07-21
4:30 pm
Purchase
2025-07-1713DESSA Pharma Inc.
EPIX
Soleus Capital Master Fund, L.P.4,362,026
9.800%
2,100,000increase
(+92.84%)
Filing
History
2025-06-16
5:00 pm
Purchase
2025-06-1313GUroGen Pharma Ltd.
URGN
Soleus Capital Master Fund, L.P.2,325,000
5.000%
2,325,000increase
(New Position)
Filing
History
2025-05-02
5:00 pm
Sale
2025-03-3113GAxoGen, Inc.
AXGN
Soleus Capital Master Fund, L.P.1,446,117
3.700%
-1,559,826decrease
(-51.89%)
Filing
History
2025-04-23
9:45 pm
Unchanged
2025-04-2313DESSA Pharma Inc.
EPIX
Soleus Capital Master Fund, L.P.2,262,026
5.100%
0
(Unchanged)
Filing
History
2025-04-16
5:37 pm
Purchase
2025-04-1513GMural Oncology plc
MURA
Soleus Capital Master Fund, L.P.1,079,927
6.300%
1,079,927increase
(New Position)
Filing
History
2025-04-15
4:46 pm
Purchase
2025-04-1513DESSA Pharma Inc.
EPIX
Soleus Capital Master Fund, L.P.2,262,026
5.100%
2,262,026increase
(New Position)
Filing
History
2025-04-11
7:30 pm
Sale
2025-04-1113DTheratechnologies Inc.
THTX
Soleus Capital Master Fund, L.P.4,801,375
10.400%
-387,501decrease
(-7.47%)
Filing
History
2025-04-01
5:00 pm
Purchase
2025-03-3113GNovoCure Limited
NVCR
Soleus Capital Master Fund, L.P.5,521,414
5.000%
5,521,414increase
(New Position)
Filing
History
2025-03-28
5:09 pm
Purchase
2025-03-2613GSTAAR Surgical Company
STAA
Soleus Capital Master Fund, L.P.2,562,893
5.200%
2,562,893increase
(New Position)
Filing
History
2025-03-19
5:00 pm
Purchase
2025-03-1813GPraxis Precision Medicines, Inc.
PRAX
Soleus Capital Master Fund, L.P.1,017,740
5.000%
1,017,740increase
(New Position)
Filing
History
Goto 0, 1, 2, 3, 4, Next